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Objective: To compare long-term results of percutaneous iliac artery stenting (PCIS) with aortobifemoral (ABF) grafting
for patients with symptomatic iliac artery occlusions.
Methods: A retrospective review of 229 patients (January 2000 to December 2011) with symptomatic iliac artery occlu-
sions was performed. In 100 patients, 103 PCIS procedures were performed, and 101 patients underwent ABF grafting.
Outcome data including periprocedural complications, improvement in ankle-brachial index, morbidity, and mortality
were collected in a vascular registry. Kaplan-Meier estimates for patency and survival were analyzed. Univariate (Fisher
exact test) and multivariate analyses of variables associated with the loss of primary patency were performed.
Results: Patients in the ABF grafting group were younger (60 ± 0.9 years old vs 65 ± 1.2 years old; P[ .002) and more
commonly had a history of nicotine abuse (97% vs 86%; P [ .002), chronic obstructive pulmonary disease (85% vs 70%;
P [ .02), and a greater incidence of superﬁcial femoral artery disease (45% vs 24%; P [ .001). The most common
presenting symptoms in both groups consisted of intermittent claudication (66% ABF vs 71% PCIS), rest pain (20% ABF
vs 17% PCIS), and ulceration or gangrene of toes (14% ABF vs 15% PCIS). At 72 months, the primary patency for ABF
bypass was greater than for PCIS (91% vs 73%; P[ .010). Secondary patency rates were equivalent in both groups (98%
ABF vs 85% PCIS). Survival in the ABF bypass group was signiﬁcantly greater than in the PCIS group (76% vs 68%; P[
.013). Hyperlipidemia (hazard ratio, 2.55; P[ .049) and concurrent superﬁcial femoral artery lesion (hazard ratio, 2.61;
P[ .026) were factors associated with the loss of primary patency for the entire cohort. The average hospital stay was 7 ±
2 days in the ABF group and 1 ± 0.3 days in the PCIS group (P [ .0001). There were no periprocedural deaths in the
PCIS group; there were four deaths in the ABF group (P [ .058). In the PCIS group, ankle-brachial index increased
from 0.66 to 0.89, and in the ABF group, ankle-brachial index increased from 0.54 to 0.98 (both groups, P < .001).
Conclusions: This study demonstrates that PCIS remains a suitable, less invasive ﬁrst-line therapy for iliac artery occlu-
sions. PCIS has lower morbidity, shorter hospital length of stay, and equivalent secondary patency but inferior primary
patency compared with ABF. (J Vasc Surg 2013;57:1030-7.)Since the introduction of synthetic grafts as an arterial
substitute for the aortoiliac system, aortobifemoral (ABF)
grafting has remained an effective and durable treatment
option for symptomatic aortoiliac occlusive disease.
However, ABF grafting is a major arterial reconstruction
with an associated mortality rate of 3% to 5%, a signiﬁcant
complication rate approaching 4% to 20%, and delayed
return to functional status.1-5
The introduction of iliac angioplasty with or without
stenting for iliac artery stenosis provided an impetus for treat-
ing iliac artery occlusions with iliac stenting.6,7 However,
initial results for percutaneous iliac artery stenting (PCIS)
for iliac artery occlusionswere unsatisfactorywith a high inci-
dence of thromboembolic complications.8 Over the past 15
years, endovascular therapy has evolved signiﬁcantly, allow-
ing interventionalists to consider iliac stenting as a ﬁrst-linethe St. John Providence Health Systema; and the Henry Ford Health
stem.b
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0treatment option for iliac artery occlusions.9-15 Apart from
low perioperativemorbidity associated with PCIS, an unsuc-
cessful attempt for endovascular recanalization does not
preclude subsequent ABF grafting.
Midterm results comparing ABF grafting with PCIS for
iliac artery occlusion revealedmarginal superiority in primary
patency for ABF bypass but equivalent secondary
patency.12,13 Previously published series reported a primary
patency rate of 54% to 76% at midterm follow-up (up to 4
years) for patients undergoing PCIS for iliac artery occlu-
sions.6,7,9-13,15 In contrast to PCIS, reported primary
patency rates for ABF grafting at midterm follow-up are
>90%.12,13 Results comparing PCIS with ABF grafting in
terms of long-term patency for iliac artery occlusions have
not been previously reported. In this study, we report our
experience over 12 yearswith PCIS andABFgrafting for iliac
artery occlusions.METHODS
Patients. After approval by the institutional review
board, a retrospective review of 229 patients (January
2000 to December 2011) with symptomatic iliac artery
occlusions at two midsized (350 beds each) teaching hospi-
tals was performed. Percutaneous iliac angioplasty and
stenting was attempted in 109 patients with 112 iliac artery
occlusions and was successful in 100 patients with 103 iliac
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ABF bypass was performed in 101 patients. The senior
author (S.S.H.) performed 44% (n ¼ 45) of the PCIS
and 80% (n ¼ 81) of the ABF bypass graft procedures.
The decision to treat iliac occlusions either by PCIS or
by ABF grafting was made by the treating surgeon or inter-
ventionalist. The ABF procedure was preferred for (1)
patients with long segment occlusions (combined common
iliac and external iliac occlusions) that were heavily calciﬁed
and with associated infrainguinal disease, (2) patients with
technically failed percutaneous intervention, (3) patients
with recurrent stent thrombosis after failed percutaneous
secondary intervention for iliac artery occlusion, and (4)
patients with a hypoplastic aorta and small-diameter
arteries distal to the iliac artery occlusion.
For purposes of this study, only patients undergoing
ABF grafting or PCIS for iliac artery occlusions were
included. Patients undergoing ileofemoral bypass grafting
(n ¼ 14); crossover femoral-femoral bypass grafting (n ¼
3); and axillofemoral bypass grafting (n ¼ 2) performed for
iliac artery occlusions were excluded. Patients undergoing
endovascular therapy for iliac artery stenoses or patients
undergoing ABF grafting for iliac artery occlusions with
associated abdominal aortic aneurysm were also excluded.
Patient demographics, risk factors, clinical presenta-
tion, procedural details, and noninvasive vascular studies
performed before and after the intervention were obtained
from a detailed review of patient hospital and ofﬁce
records. The data were kept in an ongoing vascular registry.
Original arteriogram images were retrieved and reviewed
from previously captured and stored images on Philips Xce-
lera (Eindhoven, The Netherlands) at St. John Providence
Health System and from Synapse FujiMed (Stamford,
Conn) at Henry Ford Health System.
Symptoms of lower extremity ischemia were classiﬁed
into intermittent claudication and chronic critical limb
ischemia—the latter consisting of rest pain, ischemic ulcer-
ation, and gangrene of the toes. Using the TransAtlantic
Inter-Society Consensus (TASC) II classiﬁcation16 as
a framework, common iliac artery (CIA) occlusions repre-
sented TASC B lesions, external iliac artery (EIA) occlu-
sions represented TASC C lesions, and combined CIA
and EIA occlusions represented TASC D lesions. Outcome
data such as periprocedural complications, improvement in
ankle-brachial index (ABI), morbidity, and mortality (veri-
ﬁed by the Social Security Death Index) were collected in
our vascular registry. Primary and secondary patency rates
were deﬁned according to the Society for Vascular Surgery
reporting standard for lower extremity ischemia.17
Postintervention/surgical surveillance of revasculariza-
tions consisting of clinical evaluation and noninvasive
Doppler arterial study with ABI measurements was gener-
ally done at 1 month, 3 months, 6 to 9 months, and 12
months, followed by biannual or annual follow-up.
Patients developing recurrent ischemic symptoms or signif-
icant change in ABI underwent either computed tomog-
raphy angiography or conventional digital subtraction
arteriography.Endovascular technique. All PCIS procedures were
performed in interventional radiology/cardiac catheteriza-
tion suites except for four patients who underwent simulta-
neous distal open reconstruction in the operating room.
Most PCIS procedures were performed under local anes-
thetic with conscious sedation. All endovascular procedures
were performed under systemic heparinization with admin-
istration of antiplatelet therapy (aspirin, clopidogrel) after
the procedure. Most percutaneous interventions were per-
formed via a bilateral femoral artery approach (n ¼ 53;
53%), followed by unilateral femoral artery approach (n ¼
36; 36%), combined brachial artery and femoral artery
approach (n ¼ 9; 9%), and brachial artery approach (n ¼
2; 2%). Initial arteriography was performed via retrograde
femoral access on the less affected side in most cases.
However, in many instances, the intervention (PCIS) was
performed via an ipsilateral retrograde femoral approach
on the affected side. In most patients, a hydrophilic 0.035-
inch Glidewire (Terumo Medical Corp, Somerset, NJ) or
in some cases a Magic Torque wire (Boston Scientiﬁc Corp,
Natick, Mass) was passed intraluminally or in the subintimal
plane. In 10 patients, technical aids such as the OUTBACK
LTD catheter (Cordis Johnson & Johnson, Miami, Fla)
(n ¼ 3), FRONTRUNNER catheter (Cordis Johnson &
Johnson) (n ¼ 5), and Pioneer intravascular ultrasound
catheter (Medtronic, Indianapolis, Ind) (n ¼ 2) were used
to cross chronic iliac artery occlusions. In ﬁve patients,
a goose neck snare (ev3 Endovascular Inc, Plymouth,Minn)
was used to retrieve guide wires from the contralateral side.
All patients had angioplasty performed before stenting
followed by stent placement and angioplasty after stenting.
Most stents placed in the EIA were self-expanding nitinol
stents, and most stents placed in the CIA were balloon
expandable stents. Generally, 6- to 8-mm diameter stents
were used for EIA occlusions, and 8- to 10-mm diameter
stents were used for CIA occlusions. Four patients under-
went simultaneous distal procedures (femoral endarterec-
tomy, n ¼ 3; femoral-popliteal bypass, n ¼ 1). Of 100
patients who underwent PCIS, 35 (35%) had concurrent
contralateral CIA or EIA stenosis.
Surgical technique. All ABF procedures were per-
formed in the operating room under general anesthesia
via a transperitoneal approach. In all patients, a HEMA-
SHIELD knitted Dacron graft (MAQUET, Wayne, NJ)
was used as the graft conduit. In 94 patients, the proximal
aortic anastomosis consisted of an end-to-end anasto-
mosis, and the remaining seven patients had an end-to-side
anastomosis. In patients with a patent superﬁcial femoral
artery (SFA), the distal anastomosis was performed in an
end-to-side fashion to the common femoral artery (CFA)
(n ¼ 83). In patients with an occluded SFA, the distal
anastomosis was extended into the ﬁrst 1.5 cm of the pro-
funda femoris artery (n ¼ 18).
The average length of the procedure was 3.98 6 0.99
hours. A concurrent local femoral (CFA, SFA, or profunda
femoral artery) endarterectomy was performed in 14
patients (13.9%), and unilateral or bilateral profundoplas-
ties were performed in 11 patients (10.9%). Of patients
Table I. Demographics, comorbidities, and clinical
factors of patients treated with percutaneous iliac artery
stenting (PCIS) and aortobifemoral (ABF) grafting for
iliac artery occlusions
Variable
ABF
(n ¼ 101),
No. (%)
PCIS
(n ¼ 100),
No. (%) P
Age, years, mean 6 SD 60 6 0.95 65 6 1.16 .002
Gender, male 61 (60) 57 (57) .48
Nicotine abuse 98 (97) 86 (86) .002
Hypertension 71 (70) 83 (83) .15
COPD 86 (85) 70 (70) .02
Diabetes mellitus 21 (21) 27 (27) .41
CAD 52 (51) 56 (56) .78
Hyperlipidemia 60 (59) 59 (59) .78
Symptoms
Intermittent claudication 67 (66) 71 (71) .46
Rest pain 20 (20) 17 (17) .59
Ulceration/gangrene 14 (14) 15 (15) 1.0
Distribution of iliac artery
occlusions
CIA 63 (62) 57 (57) .40
EIA 15 (15) 32 (32) .008
CIA and EIA 23 (23) 14 (14) .07
Infrainguinal disease
SFA 46 (46) 24 (24) .001
POP 14 (14) 8 (8) .18
Crural 2 (2) 9 (9) .06
CAD, Coronary artery disease; COPD, chronic obstructive pulmonary
disease; CIA, common iliac artery; EIA, external iliac artery; POP, popliteal
artery; SD, standard deviation; SFA, superﬁcial femoral artery.
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concurrent contralateral common iliac or external iliac
artery stenosis.
Statistical methods. Descriptive statistics were used to
analyze comorbidities, distribution of symptoms, and
distribution of lesions. Primary patency, secondary patency,
and patient survival were analyzed with Kaplan-Meier
survival curves and the log-rank test. Univariate analysis
(Fisher exact test) of variables associated with loss of
primary patency and multivariate analysis for risk factors
associated with loss of primary patency were performed via
a Cox proportional hazards model. Continuous measures
were compared using the Student independent sample t-
tests. P < .05 and a 95% conﬁdence interval were criteria
for statistical signiﬁcance. IBM SPSS v19.0 for Windows
(Chicago, Ill) was used for all statistical computations.
RESULTS
Patients in the ABF group were younger (60 6 0.9
years old vs 65 6 1.2 years old; P ¼ .002) and more
commonly had a history of nicotine abuse (97% vs 86%;
P ¼ .002), COPD (85% vs 70%; P ¼ .02), and SFA occlu-
sive disease (46% vs 24%; P ¼ .001) (Table I). Other clin-
ical variables, such as gender, hypertension, diabetes
mellitus, coronary artery disease, and hyperlipidemia,
were similar in both groups. The most common presenting
symptoms in both groups consisted of intermittent claudi-
cation (66% ABF vs 71% PCIS; P ¼ .46), rest pain (20%
ABF vs 17% PCIS; P ¼ .59), and ulceration or gangrene
of toes (14% ABF vs 15% PCIS; P ¼ 1).
The distribution of the iliac artery occlusions (CIA,
EIA, or combined CIA and EIA) was relatively similar in
both groups. However, a greater number of patients with
EIA occlusions were treated with PCIS compared with
ABF grafting (32% vs 15%; P ¼ .008). This difference is
attributable to the exclusion of 14 patients undergoing
ileofemoral bypass grafting for EIA occlusions. If these
patients were included in the analysis, there would be no
difference in the distribution of EIA occlusions between
PCIS and ABF graft groups (32% vs 29%; P ¼ .446).
Most patients (96%) underwent PCIS with local anes-
thesia, and all patients undergoing ABF grafting had
general anesthesia. Four patients (4%) undergoing PCIS
required treatment for concomitant infrainguinal disease;
three patients required simultaneous femoral endarterec-
tomy, and one patient required a femoral-popliteal bypass.
In the ABF group, 25 patients (24.8%) underwent
a combined outﬂow procedure; 14 patients (13.9%) under-
went local femoral (CFA, SFA, or profunda femoral artery)
endarterectomy, and 11 patients (10.9%) underwent unilat-
eral or bilateral profundoplasties.
The average hospital stay in the ABF group was 7 6 2
days compared with 1 6 0.3 days in the PCIS group (P ¼
.0001). Tables II and III summarize complications
encountered in the PCIS group and ABF bypass group.
The most serious complication of PCIS was iliac rupture
(n ¼ 3), which was successfully treated by emergent ABF
grafting (n ¼ 1), prolonged balloon inﬂation (n ¼ 1),and deployment of a covered stent (n ¼ 1). In one patient,
rupture of a mycotic iliac artery pseudoaneurysm after EIA
stent placement resulted in a high above-knee amputation.
The most common complications encountered in the ABF
patients were pulmonary: pneumonia (n ¼ 13) and atelec-
tasis (n ¼ 4). A graft infection (Staphylococcus aureus)
developed in one patient in the ABF group, requiring
removal of the Dacron graft. This patient underwent
autogenous vein reconstruction (spiral vein graft) with
a satisfactory outcome to date (7 years). There were no
deaths in the PCIS group, whereas there were 4 deaths
(4%) in the ABF bypass group (P ¼ .058).
The mean follow-up for patients who underwent ABF
was 63 6 6.3 months, and mean follow-up for patients
who underwent PCIS was 38 6 2.6 months. In both
groups, postoperative ABI increased signiﬁcantly. In the
PCIS group, patients had an ABI increase from 0.66 6
0.17 to 0.89 6 0.17; patients in the ABF bypass group
had an increase from 0.54 6 0.18 to 0.98 6 0.16 (for
both groups, P < .001).
The primary patency (Fig 1, A) for patients undergoing
ABF bypass was signiﬁcantly higher than for patients
undergoing PCIS (91% vs 73%; P ¼ .010). In 16 patients
(n ¼ 16), PCIS failed, as conﬁrmed by computed tomog-
raphy angiography or conventional digital subtraction arte-
riography. Of the 16 patients, eight patients were treated
by placing additional iliac stents, three patients had tissue plas-
minogen activator thrombolysis performed with subsequent
Table II. Periprocedural complications encountered in percutaneous iliac artery stenting (PCIS) groupa
Complications No. (%) Management and outcome
Groin hematoma 4 (4) Observed
Rupture of iliac artery 3 (3) One patient required emergent surgical repair (ABF); one controlled with prolonged
low-pressure balloon inﬂation; one required placement of covered stent
Dissection (non-ﬂow limiting)
CIA 2 (2) Observed
SFA 1 (1)
Aortic 2 (2)
Distal embolization 3 (3) Two patients treated with open embolectomy; one treated with tissue plasminogen
activator thrombolysis
Femoral pseudoaneurysm 1 (1) Treated with ultrasound-directed thrombin injection
Rupture of mycotic left iliac
pseudoaneurysm
1 (1) Surgical repair; subsequently requiring high above-knee amputation
Brachial artery occlusion 2 (2) One patient treated with open thrombectomy; one observed
Amputation 1 (1) Despite successful revascularization, patient required left above-knee amputation
secondary to complex calcaneal fracture with superimposed infection
Mortality 0
ABF, Aortobifemoral grafting; CIA, common iliac artery; SFA, superﬁcial femoral artery.
an ¼ 100.
Table III. Perioperative complications encountered in aortobifemoral (ABF) grafting groupa
Complications (%) No. Management and outcome
Vascular (2)
Acute graft limb thrombosis 1 Graft limb thrombectomy
Infected graft 1 Removal of infected graft and replacement with spiral
vein graft
Pulmonary (16.8)
Pneumonia 13 Resolved with antibiotics and incentive spirometry
Atelectasis 4
Cardiac (4)
CHF 2 Medical management
Myocardial infarction 1
Atrial ﬁbrillation 1
Gastrointestinal (11.9)
Ileus 9 Medical management
Acute pancreatitis 2
Ischemic colitis 1 Required sigmoid colectomy
Neurologic (1)
Stroke 1 Medical management
Surgical site infection (4)
Groin 4 Two patients required surgical debridement; two were
given antibiotics and observed
Mortality (4) 4 Two patients died of myocardial infarction; one died
of complications of pancreatitis; one died of DIC.
CHF, Congestive heart failure; DIC, disseminated intravascular coagulation.
an ¼ 101.
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tissue plasminogen activator thrombolysis, one patient had
balloon angioplasty, one patient underwent ABF bypass,
and one patient did not undergo any intervention. In the
ABF grafting group, eight patients had graft limb occlu-
sion; seven patients underwent open thrombectomy of
the affected limb of the graft, and one patient had tissue
plasminogen activator thrombolysis with subsequent throm-
bectomy of the graft limb. The difference in secondary
patency (Fig 1, B) rates between the ABF bypass and
PCIS groups (98% vs 85%; P ¼ .141) was not statisticallysigniﬁcant. For the difference in secondary patency rates
to be statistically signiﬁcant, each group would have been
required to have 143 patients. The survival rate in the
ABF bypass group was signiﬁcantly higher than in the
PCIS group (76% vs 68%; P ¼ .013) (Fig 2).
A univariate analysis of demographics, comorbidities,
clinical factors, and their association with loss of primary
patency was performed (Table IV). None of the variables
analyzed were statistically signiﬁcant. A stepwise logistic
regression multivariate analysis of independent variables
(age, coronary artery disease, COPD, hypertension,
Fig 1. A, Kaplan-Meier survival curves for primary patency in
patients treated with aortobifemoral grafting (ABF) and percuta-
neous iliac artery stenting (PCIS) at 72 months (91% vs 73%; P ¼
.010). B, Secondary patency for patients undergoing ABF bypass
vs PCIS was 98% vs 85% (P ¼ .141).
Fig 2. Survival rate for patients undergoing aortobifemoral (ABF)
bypass was signiﬁcantly greater for patients undergoing percuta-
neous iliac artery stenting (PCIS) (76% vs 68%; P ¼ .013).
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iliac artery occlusion with ipsilateral SFA occlusive disease)
associated with the loss of primary patency for the entire
cohort was performed. Signiﬁcant independent predictors
were hyperlipidemia (hazard ratio, 2.55; P ¼ .049) and
presence of iliac artery occlusion (CIA, EIA, or both)
with ipsilateral SFA involvement (hazard ratio, 2.6; P ¼
.026). However, when a stepwise logistic regression (with
the same independent variables) was performed for the
ABF bypass group and PCIS group separately, there wereno statistically signiﬁcant independent predictors for loss
of primary patency in the ABF bypass group. The presence
of ipsilateral SFA disease with iliac artery occlusion was an
independent risk factor associated with loss of primary
patency in the PCIS group (hazard ratio, 3.27; P ¼ .017).
DISCUSSION
Our study demonstrates that ABF grafting is an effec-
tive and durable vascular reconstructive option for iliac
artery occlusions. However, PCIS is a suitable alternative
treatment option with satisfactory primary patency, excel-
lent secondary patency, lower morbidity, and shorter
hospital length of stay compared with ABF grafting. To
our knowledge, this the ﬁrst case series comparing long-
term results of PCIS with ABF grafting for iliac artery
occlusions in >200 patients from a contemporary vascular
practice.
ABF grafting is associated with a perioperative mortality
rate of 4.4% to 8.1%1,13 and major morbidity rate of 3.5% to
22%.1,13 PCIS is associatedwith lower perioperativemortality
(1%-4.8%) and morbidity (1%-14%) when compared with
ABF grafting.6,13,15 In our series, there were no periproce-
dural deaths in the PCIS group, but four patients (4%) died
after ABF grafting (P ¼ .058).
The PCIS procedure for iliac artery occlusions is techni-
cally more challenging than PCIS for iliac artery stenosis
even if simultaneous open repair of the stenotic lesion in
the CFA is required. The TASC II classiﬁcation consensus
updated in 2007 provides a useful framework to assess the
treatment strategies for aortoiliac occlusive disease by
deﬁning the morphology and extent of the occlusive
process.16 According to the TASC II classiﬁcation, TASC
Table IV. Univariate analysis of variables for loss of primary patency in patients treated with percutaneous iliac artery
stenting (PCIS) and aortobifemoral (ABF) grafting for iliac artery occlusions
Variable HR (95% CI) P Variable HR (95% CI) P
Age (mean year) <60 Symptoms
All 1.62 (0.71-3.7) .29 Intermittent claudication
PCIS 1.44 (0.50-4.14) .58 All 0.55 (0.24-1.27) .18
ABF 3.65 (0.69-19) .15 PCIS 0.65 (0.23-1.89) .42
ABF 0.32 (0.71-1.4) .14
Gender, female Rest pain
All 1.44 (0.61-3.41) .53 All 1.42 (0.53-3.83) .59
PCIS 0.75 (0.27-2.12) .61 PCIS 1.58 (0.45-5.57) .49
ABF 0.48 (0.92-2.52) .47 ABF 1.39 (0.26-7.46) .66
Ulceration/gangrene
Nicotine abuse All 2 (0.74-5.56) .22
All 0.54 (0.17-1.78) .30 PCIS 1.22 (0.31-4.85) .72
PCIS 0.99 (0.25-3.87) 1.00 ABF 4.47 (0.94-21.4) .08
ABF 0.15 (0.01-1.92) .22
Iliac occlusion
Hypertension CIA
All 1.92 (0.63-5.86) .33 All 0.65 (0.29-1.48) .39
PCIS 2.15 (0.45-10.2) .51 PCIS 0.73 (0.27-2.04) .61
ABF 1.29 (0.25-6.80) 1.00 ABF 0.58 (0.13-2.45) .47
EIA
COPD All 1.58 (0.64-3.92) .32
All 1.34 (0.48-3.77) .81 PCIS 1.14 (0.39-3.36) .79
PCIS 0.99 (0.25-3.87) 1.00 ABF 2.05 (0.37-11.3) .34
ABF 1.36 (0.26-7.15) 1.00 CIA and EIA
All 1.13 (0.39-3.23) .79
Diabetes mellitus PCIS 1.5 (0.37-6.10) .70
All 1.89 (0.78-4.56) .21 ABF 1.14 (0.21-6.09) 1.00
PCIS 2.07 (0.71-6.04) .24
ABF 1.30 (0.24-6.95) .67 Infrainguinal disease
SFA
CAD All 2.13 (0.93-4.87) .08
All 1.5 (0.65-3.47) .40 PCIS 2.54 (0.86-7.54) .12
PCIS 1.06 (0.38-2.95) 1.00 ABF 3.95 (0.77-20.7) .14
ABF 3.06 (0.59-15.9) .27 POP
All 0.66 (0.15-2.99) .75
Hyperlipidemia PCIS 1.65 (0.30-8.90) .63
All 2.66 (1.02-6.94) .05 ABF 0.91 (0.85-0.97) .60
PCIS 2.20 (0.72-6.73) .13 Crural
ABF 5.28 (0.63-44.8) .14 All 1.56 (0.32-7.68) .64
PCIS 1.39 (0.27-7.33) .66
ABF 0.92 (0.87-0.97) 1.00
CAD, Coronary artery disease; CI, conﬁdence interval; COPD, chronic obstructive pulmonary disease; CIA, common iliac artery; EIA, external iliac artery;
HR, hazard ratio; POP, popliteal artery; SFA, superﬁcial femoral artery.
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stenotic lesions in the EIA extending into the CFA. Patients
with combined ipsilateral CIA and EIA occlusion are classi-
ﬁed as TASC D lesions. However, TASC D lesions may also
include patients with diffuse multiple stenoses involving the
ipsilateral CIA, EIA, and CFA or CIA stenoses associated
with abdominal aortic aneurysm deemed unsuitable for
endovascular or open repair. Comparing PCIS with open
arterial reconstruction according to the extent of iliac artery
occlusion rather than using the TASC II classiﬁcation
(which may include stenotic lesions) appears to provide
a more meaningful analysis.
During this 12-year interval, we had similar use of both
open and endovascular treatment options for CIA and
combined CIA and EIA occlusions. However, a greater
number of patients with EIA occlusion underwent PCIScompared with ABF grafting (32% vs 15%; P ¼ .008)
because 14 patients undergoing ileofemoral grafting for
EIA occlusion as part of open reconstruction were excluded
from the analysis.
Establishment of adequate outﬂow is of paramount
importance in patients undergoing endovascular or open
revascularization for iliac artery occlusions. Previously re-
ported rates of combined outﬂow procedure in conjunc-
tion with endovascular recanalization ranged from 11.5%
to 21%.6,13,15 Kashyap et al13 reported that 50% of patients
undergoing ABF grafting required a unilateral or bilateral
femoral endarterectomy, a profundoplasty, or both. In
our study, 4% of patients undergoing PCIS required treat-
ment for concomitant infrainguinal disease, and 24.8% of
patients in the ABF group underwent a combined outﬂow
procedure. No statistically signiﬁcant difference was noted
Fig 3. The pattern of interventions performed for iliac artery occlusions over the study period. ABF, Aortobifemoral
grafting; PCIS, percutaneous iliac artery stenting.
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grafting group who underwent an outﬂow procedure (n ¼
25) versus the patients who did not require an outﬂow
procedure (91% vs 80%; P ¼ .28).
The PCIS procedure for long segment iliac artery
occlusions can be technically challenging. Technical success
was unsatisfactory in patients with heavily calciﬁed iliac
artery occlusions. Ultrasound guidance for puncture of
the pulseless femoral artery or the use of roadmapping
were helpful for arterial entry. In some patients, bilateral
femoral artery and left brachial artery puncture was neces-
sary for successful PCIS. Technical aids to cross chronic
total occlusions were helpful in some patients, but most
chronic iliac artery occlusions were crossed with a hydro-
philic 0.035-inch Glidewire (Terumo Medical Corp) used
in conjunction with an angled catheter such as a 5F Kumpe
catheter (Cook, Inc, Bloomington, Ind) or a Berenstein
catheter (AngioDynamics, Latham, NY) in a coaxial
manner. In patients with subintimal location of the guide-
wire, re-entry of the catheter into the true lumen both
above and below the recanalized segment before balloon
inﬂation or deployment of stent was ensured. Chen
et al15 reported excellent results with subintimal angio-
plasty as ﬁrst-line therapy in patients with chronic total
occlusions of the iliac artery.
The reported primary patency rates for patients under-
going PCIS for iliac artery occlusions are 76% at 2 years,6
69% to 76% at 3 years,10,13,15 54% to 76% at 4 years,7,9,12
and 63% at 5 years.11 We observed a primary patency rate
of 73% at 72 months for patients undergoing PCIS for iliac
artery occlusions. Secondary patency rates range from 80%
to 95%9-13,15 and are similar to results reported in this
study (85%).
The reported primary patency of ABF is 85% to 91% at
5 years and 82% to 87% at 10 years.1-5 Our results are
similar to previously published data. We observed 91%primary patency and 98% secondary patency rates at 6 years
after ABF grafting.
Kashyap et al13 provided the ﬁrst detailed comparison
of PCIS versus open arterial reconstruction for aortoiliac
occlusive disease. These authors observed that patients
with diabetes mellitus or distal arterial occlusive disease
requiring a bypass were at greater risk for loss of primary
patency. They also reported decreased primary patency
rates in patients <60 years old undergoing endovascular
recanalization. Similarly, patients <65 years old and
patients with a small-diameter aorta undergoing ABF graft-
ing are reported to have decreased primary patency.4,5 The
univariate analysis in our study failed to reveal a signiﬁcant
variable associated with loss of primary patency. The step-
wise logistic regression multivariate analysis of independent
variables revealed two factors associated with loss of
primary patency for the entire cohort. Patients with hyper-
lipidemia or concurrent iliac artery occlusion with SFA
disease were 2.5 or 2.6 times more likely to have a decrease
in primary patency.
The survival rate reported in the present study for
patients undergoing PCIS was lower than for patients
undergoing ABF grafting (68% vs 76%; P ¼ .013). Kashyap
et al13 reported equal survival rates in patients undergoing
PCIS and ABF bypass (80% for both groups). The lower
survival rate observed in the PCIS group is probably due
to the older age of the patients at the time of intervention
in our study.
In the present study ranging from 2000 to 2011, ABF
grafting was performed in 68.3% of patients during the ﬁrst
6 years of the study. However, in the ensuing 6 years, 73%
of patients underwent PCIS as ﬁrst-line therapy for iliac
artery occlusions (Fig 3). This change has been attributed
to the increasing experience of interventionalists and avail-
ability of technical aids to cross chronic iliac artery occlu-
sions.12-15 The main limitations of this case series are that
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selection for PCIS or ABF grafting was decided by the
attending vascular surgeons or interventionalists according
to their best clinical judgment. Ideally, a prospective
randomized trial is required to compare the outcome of
PCIS or ABF grafting as treatment modalities for iliac
artery occlusions. However, in practice, such a trial would
be difﬁcult to carry out because patients given the choice
between PCIS and ABF grafting invariably prefer a less
invasive approach.
CONCLUSIONS
Both PCIS and ABF grafting as revascularization
modalities for iliac artery occlusions have excellent tech-
nical success rates. Primary patency is signiﬁcantly greater
with ABF grafting. However, secondary patency at 6 years
is equivalent with both techniques. A shorter length of
hospital stay, lower morbidity, and a quick return to prein-
tervention activities are signiﬁcant advantages of PCIS. In
some instances, failed initial percutaneous intervention
can be treated with secondary PCIS. If secondary PCIS is
unsuccessful or is not feasible, the option of ABF grafting
is not precluded.
The authors thank Dr Sherezade Khambatta for her
assistance in the preparation of the manuscript.
AUTHOR CONTRIBUTIONS
Conception and design: SH, GS
Analysis and interpretation: SH, GS
Data collection: SH, GS, MD, TK, MM, YR, JZ, LS
Writing the article: SH, GS
Critical revision of the article: SH, GS, MD, TK, MM, YR,
JZ, LS
Final approval of the article: SH, GS, MD, TK, MM, YR,
JZ, LS
Statistical analysis: MK
Obtained funding: Not applicable
Overall responsibility: SH
REFERENCES
1. de Vries SO, Hunink MG. Results of aortic bifurcation grafts for aor-
toiliac occlusive disease: a meta-analysis. J Vasc Surg 1997;26:558-69.2. Szilagyi DE, Elliott JP Jr, Smith RF, Reddy DJ, McPharlin M. A thirty-
year survey of the reconstructive surgical treatment of aortoiliac
occlusive disease. J Vasc Surg 1986;3:421-36.
3. Poulias GE, Doundoulakis N, Prombonas E, Haddad H,
Papaioannou K, Lymberiades D, et al. Aorto-femoral bypass and
determinants of early success and late favourable outcome: experience
with 1000 consecutive cases. J Cardiovasc Surg (Torino) 1992;33:
664-78.
4. Hertzer NR, Bena JF, Karafa MT. A personal experience with direct
reconstruction and extra-anatomic bypass for aortoiliofemoral occlusive
disease. J Vasc Surg 2007;45:527-35.
5. Reed AB, Conte MS, Donaldson MC, Mannick JA, Whittemore AD,
Belkin M. The impact of patient age and aortic size on the results of
aortobifemoral bypass grafting. J Vasc Surg 2003;37:1219-25.
6. Sullivan TM, Childs MB, Bacharach JM, Gray BH, Piedmonte MR.
Percutaneous transluminal angioplasty and primary stenting of the iliac
arteries in 288 patients. J Vasc Surg 1997;25:829-38.
7. Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous
transluminal angioplasty and stent placement for aortoiliac occlusive
disease. Radiology 1997;204:87-96.
8. Ring EJ, Freiman DB, McLean GK, Schwarz W. Percutaneous recan-
alization of common iliac artery occlusions: an unacceptable compli-
cation rate? AJR Am J Roentgenol 1982;139:587-9.
9. Scheinert D, Schroder M, Ludwig J, Braunlich S, Mockel M,
Flachskampf FA, et al. Stent-supported recanalization of chronic iliac
artery occlusions. Am J Med 2001;110:708-15.
10. Uher P, Nyman U, Lindh M, Lindblad B, Ivancev K. Long-term
results of stenting for chronic iliac artery occlusion. J Endovasc Ther
2002;9:67-75.
11. Ozkan U, Oguzkurt L, Tercan F. Technique, complication, and long-
term outcome for endovascular treatment of iliac artery occlusion.
Cardiovasc Intervent Radiol 2010;33:18-24.
12. Hans SS, DeSantis D, Siddiqui R, Khoury M. Results of endovascular
therapy and aortobifemoral grafting for Transatlantic Inter-Society type
C and D aortoiliac occlusive disease. Surgery 2008;144:583-9.
13. Kashyap VS, Pavkov ML, Bena JF, Sarac TP, O’Hara PJ, Lyden SP,
et al. The management of severe aortoiliac occlusive disease: endo-
vascular therapy rivals open reconstruction. J Vasc Surg 2008;48:
1451-7.
14. Kondo Y, Dardik A, Muto A, Koizumi J, Nishibe M, Nishibe T.
Primary stent placement for iliac artery chronic total occlusions. Surg
Today 2010;40:433-9.
15. Chen BL, Holt HR, Day JD, Stout CL, Stokes GK, Panneton JM.
Subintimal angioplasty of chronic total occlusion in iliac arteries: a safe
and durable option. J Vasc Surg 2011;53:367-73.
16. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA,
Fowkes FG. Inter-Society Consensus for the Management of Periph-
eral Arterial Disease (TASC II). J Vasc Surg 2007;45(Suppl S):S5-67.
17. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S,
et al. Recommended standards for reports dealing with lower extremity
ischemia: revised version. J Vasc Surg 1997;26:517-38.
Submitted Jun 27, 2012; accepted Sep 6, 2012.
